DALIRESP® (roflumilast) Mechanism of Action | For HCPs
Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells | Acta Pharmacologica Sinica
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
FCPR03 is a Selective Phosphodiesterase 4 (PDE4) Inhibitor - Immune System Research
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders - ScienceDirect
Treating brain tumors with PDE4 inhibitors: Trends in Pharmacological Sciences
File:Mechanism of action of PDE4 inhibitor.jpg - Wikimedia Commons
Phosphodiesterase inhibitors - Knowledge @ AMBOSS
Reducing Neuroinflammation in Psychiatric Disorders: Novel Target of Phosphodiesterase 4 (PDE4) and Developing of the PDE4 Inhibitors | IntechOpen
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases | Pharmacology
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Phosphodiesterase-4 inhibitor - Wikipedia
PDE4 inhibition reduces the release of a variety of pro-inflammatory... | Download Scientific Diagram
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling - ScienceDirect
R)-(-)-Rolipram, Selective PDE4 inhibitor (CAS 85416-75-7) (ab120031) | Abcam
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
PLOS ONE: Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis
Rolipram is a Selective Phosphodiesterases PDE4 Inhibitor - Immune System Research
Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway - ScienceDirect
Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate: Molecular Therapy
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity | Reumatología Clínica
Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis - ScienceDirect
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook | Semantic Scholar
